Bennett Levitan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Pulmonary Embolism

Magnetic Resonance

Drug Administration

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M Bauersachs, Scott D Berkowitz, Lloyd P Haskell, Elliot S Barnathan, Marc P Bonaca
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial. Journal of the American Heart Association (2024)
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M Bauersachs, Scott D Berkowitz, Lloyd P Haskell, Elliot S Barnathan, Marc P Bonaca
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial. Journal of the American Heart Association 13 (8) (2024)
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M Bauersachs, Scott D Berkowitz, Lloyd P Haskell, Elliot S Barnathan, Marc P Bonaca
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial. Journal of the American Heart Association 13 (8) (2024)
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M Bauersachs, Scott D Berkowitz, Lloyd P Haskell, Elliot S Barnathan, Marc P Bonaca
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial. Journal of the American Heart Association 13 (8) (2024)
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M Bauersachs, Scott D Berkowitz, Lloyd P Haskell, Elliot S Barnathan, Marc P Bonaca
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial. Journal of the American Heart Association 13 (8) (2024)
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M Bauersachs, Scott D Berkowitz, Lloyd P Haskell, Elliot S Barnathan, Marc P Bonaca
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial. Journal of the American Heart Association 13 (8) (2024)
Axel Christian Mühlbacher, Esther Wilhelmina de Bekker-Grob, Oliver Rivero-Arias, Bennett Levitan, Caroline M Vass
How to Present a Decision Object in Health Preference Research: Attributes and Levels, the Decision Model, and the Descriptive Framework. The patient (2024)
Cathy Anne Pinto, Tommi Tervonen, Aura Cecilia Jimenez-Moreno, Bennett Levitan, Montse Soriano Gabarró, Cynthia J Girman, Josephine M Norquist, A Brett Hauber
Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey. The patient (2023)
Ian P Smith, Rachael L DiSantostefano, Esther Wilhelmina de Bekker-Grob, Bennett Levitan, Conny Berlin, Jorien Veldwijk, G Ardine de Wit
Methodological Priorities for Patient Preferences Research: Stakeholder Input to the PREFER Public-Private Project. The patient 14 (5) (2021)